Nuvectis Pharma, Inc. NVCT Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Nuvectis Pharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Nuvectis Pharma, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvectis Pharma, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvectis Pharma, Inc.'s total liabilities?
- Nuvectis Pharma, Inc. (NVCT) reported total liabilities of $11.18M in Q1 2026.
- How has Nuvectis Pharma, Inc.'s total liabilities changed year-over-year?
- Nuvectis Pharma, Inc.'s total liabilities increased by 21.6% year-over-year, from $9.19M to $11.18M.
- What is the long-term trend for Nuvectis Pharma, Inc.'s total liabilities?
- Over 4 years (2021 to 2025), Nuvectis Pharma, Inc.'s total liabilities has grown at a 53.1% compound annual growth rate (CAGR), from $2.42M to $13.3M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.